Ambulatory Versus Home Blood Pressure Monitoring in Obstructive Sleep Apnea

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01685736

Acronym

OSA

Enrollment

Registered

2012-09-14

Start date

2012-02-29

Completion date

2013-06-30

Last updated

2012-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension, Obstructive Sleep Apnoea

Brief summary

Subjects referred to a sleep clinic had polysomnography (PSG), clinic BP measurements, 24-hour ABP monitoring and HBP monitoring using a device (Microlife WatchBP HomeN) that allows daytime (3 days, 2 duplicate readings/day) and automated nighttime BP measurement (3 nights, 3 readings/night).

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 65 Years

Healthy volunteers

Inclusion criteria

* Age ≤ 65 years * Suspected OSA * Treated or untreated for hypertension

Exclusion criteria

* History of cardiovascular disease (heart failure, coronary heart disease, arrhythmia or stroke) * History of asthma or chronic obstructive pulmonary disease (FEV1/FVC \<70%) * History of diabetes mellitus, collagen diseases and sarcoidosis * Serum creatinine \>1.6 mg/dl, proteinuria * Previous treatment with CPAP * Pregnancy or menstruation during the study * Treatment with steroids, lithium or any other drugs affecting BP * Change in antihypertensive treatment(if any) in the last 8 weeks before study entry

Countries

Greece

Outcome results